Purchases and Sales Made in Q4 2022 in Replimune Group, Inc. (REPL)
This table provides information about the institutional ownership of Replimune Group, Inc. (REPL) during Q4 2022. The information is specifically focused on institutions that hold shares of Replimune Group, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2023
Q4 2022
|
State Of Wisconsin Investment Board
Madison, WI |
SELL
|
- |
-148- 0.61% |
$2.53K - $4.13K
|
24.1K
$309K
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-438- 84.72% |
$7.49K - $12.2K
|
79
$1.01K
|
|
Jan 20, 2023
Q4 2022
|
Harbor Capital Advisors, Inc.
|
SELL
|
- |
-583- 2.11% |
$9.96K - $16.3K
|
27.1K
$346K
|
|
Feb 13, 2023
Q4 2022
|
Barclays PLC
London, X0 |
SELL
|
- |
-1.53K- 3.08% |
$26.1K - $42.7K
|
48.1K
$616K
|
|
Feb 14, 2023
Q4 2022
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-1.99K- 0.92% |
$34K - $55.5K
|
215K
$2.75M
|
|
Feb 14, 2023
Q4 2022
|
Virtus ETF Advisers LLC
New York, NY |
SELL
|
- |
-2.13K- 29.83% |
$36.5K - $59.6K
|
5.02K
$64.2K
|
|
Jun 14, 2023
Q4 2022
|
Met Life Investment Management, LLC
Whippany, NJ |
SELL
|
- |
-2.95K- 12.0% |
$50.4K - $82.3K
|
21.6K
$277K
|
|
Feb 02, 2023
Q4 2022
|
Sg Americas Securities, LLC
|
SELL
|
- |
-4.9K- 26.34% |
$83.8K - $137K
|
13.7K
$175K
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-6.36K- 70.87% |
$109K - $178K
|
2.62K
$33.5K
|
|
Feb 14, 2023
Q4 2022
|
Osterweis Capital Management Inc
San Francisco, CA |
SELL
|
- |
-10.3K- 8.27% |
$176K - $287K
|
114K
$1.46M
|
|
Feb 14, 2023
Q4 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-10.8K- 8.8% |
$185K - $301K
|
112K
$1.43M
|
|
May 21, 2024
Q4 2022
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
SELL
|
- |
-11.3K- 95.72% |
$193K - $315K
|
505
$6.46K
|
|
Feb 13, 2023
Q4 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-12.2K- 7.39% |
$208K - $340K
|
153K
$1.95M
|
|
Feb 14, 2023
Q4 2022
|
Vident Investment Advisory, LLC
Alpharetta, GA |
SELL
|
- |
-15.1K- 35.88% |
$259K - $423K
|
27.1K
$346K
|
|
Feb 10, 2023
Q4 2022
|
Letko, Brosseau & Associates Inc
Montreal, A8 |
SELL
|
- |
-15.3K- 67.0% |
$261K - $426K
|
7.53K
$96.2K
|
|
Feb 14, 2023
Q4 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-21.6K- 51.21% |
$368K - $602K
|
20.5K
$263K
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-34.8K- 18.81% |
$595K - $971K
|
150K
$1.92M
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-34.8K- 18.81% |
$595K - $971K
|
150K
$1.92M
|
|
Feb 09, 2023
Q4 2022
|
Citigroup Inc
|
SELL
|
- |
-35.9K- 51.2% |
$613K - $1M
|
34.2K
$437K
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-90K- 13.94% |
$1.54M - $2.51M
|
556K
$7.11M
|
|
Feb 13, 2023
Q4 2022
|
Artal Group S.A.
Luxembourg, N4 |
SELL
|
- |
-200K- 22.22% |
$3.42M - $5.58M
|
700K
$8.95M
|
|
Feb 13, 2023
Q4 2022
|
Omega Fund Management, LLC
Boston, MA |
SELL
|
- |
-926K- 21.6% |
$15.8M - $25.9M
|
3.36M
$43M
|
|
Feb 14, 2023
Q4 2022
|
Atlas Venture Life Science Advisors, LLC
|
SELL
|
- |
-1.01M- 32.49% |
$17.3M - $28.2M
|
2.1M
$26.8M
|